Type 1 Diabetes Trial, Recruiting NCT06315725 Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06315725
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Type 1 Diabetes (T1D)
  • Your HbA1c (a measure of average blood sugar over the past few months) is 8% or below
  • You currently use an insulin pump to manage your diabetes
  • You are an adult between 18 and 45 years old, of any gender
  • Your Body Mass Index (BMI) falls between 18.5 and 29.9 (a measure of body weight relative to height)
  • You are a non-smoker
  • You speak English or French
  • You are able to eat chicken and fish

Who may not be able to join:

  • You have a major health condition (other than Type 1 Diabetes) that could affect how your body processes food or energy
  • You have a significant medical diagnosis other than Type 1 Diabetes
  • You have a current problem with alcohol or substance use
  • You have or have had an eating disorder, or a condition that affects how your body absorbs food
  • You have inflammatory bowel disease (a condition causing ongoing inflammation in the digestive system)
  • You feel that your sense of taste or smell is not working properly
  • You have a known medical condition affecting your taste or smell, such as the inability to smell (anosmia)
  • You are currently pregnant or breastfeeding
  • You have any food allergies or intolerances
  • You dislike the drinks used in the study (confirm with trial site)
  • You have ever had weight-loss (bariatric) surgery in the past
  • You regularly consume Gymnema sylvestre (a herbal supplement)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 514-398-3020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Registry
ClinicalTrials.gov
Start date
12 November 2024
Est. completion
1 November 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Effectiveness and optimal time course of sweet test blockade on sweet taste perception in healthy individuals; Mean plasma glucose, basal and bolus insulin changes in individuals with T1D on AP following beverage consumption.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov